Dr. Clark serves or has served as Consultant/Collaborator/PI for VA GLAHS, NSF XSEDE at University of Illinois’ NCSA, & BioCoRE at University of Illinois’ NIH CMMB; Senior Scientist/VP of Finance & Partnership Development at Complex Biological Systems Alliance; Member of Penn Center for Innovation Expert Network at UPenn; Member of Berkeley Lab’s Molecular Foundry User Program Community; Entrepreneurial Program Finalist at Stanford School of Medicine’s Brainstorm Innovation Lab; Computational Neurolinguist/Ethnobiologist at Alliance for Linguistic Diversity & Google’s The Endangered Languages Project; IEEE Brain Initiative Member & Analytics Platform Consultant; NASA Global Exploration Roadmap Workshop & NAI Virus Focus Group Member; NASA ARC Research Affiliate; Director at Felidae Conservation Fund; Guest Expert for NASEM Projects & Workshops; Science/Business Advisor to for-/nonprofit organizations promoting new, rediscovery, & translational medical science, clinical practice, & biotechnology; Postdoctoral Fellow at MPI for Biological Cybernetics; Laboratory Coordinator & Basic/Clinical Science Predoctoral Fellow at Southern Illinois University; Member of many professional societies; Editor for professional journals & technical books; Manager/Technical Advisor/Mentor for STEAM scholastic, entrepreneurial, & community outreach programs sponsored by SFN, HHMI, NSF, & The Franklin Foundation for Innovation, where he serves as CPO, Director, & First Vice Chairperson. He has (co)authored over 60 peer-review scientific journal articles & book chapters, helped generate millions of US dollars in research funding, licensed several patents, & received extensive multimedia press attention for collaborative science, entrepreneurial, & charitable activities. Dr. Clark’s award-winning research & patented inventions improving learning, memory, & recovery from TBI through peripheral neuromodulation gained recognition from US NASEM members. This work involving cognitive-emotional restructuring helped launch the field of targeted neuroplasticity training & was instrumental in FDA’s decision to approve VNS for complex-partial seizures. It has since encouraged various potential derivative medical indications for VNS. Dr. Clark combines his efforts on targeted neuroplasticity training & cognitive-emotional restructuring with innovative mobile machine-learning platforms to achieve personalized realtime prophylaxes/treatments for neuropsychiatric conditions & improved human performance. Complementing these interests, he pursues research, stemming from past collaborations with Dr. Sidney Fox, student & colleague of Nobelists Thomas Morgan & Linus Pauling, on rational design & application of smart pharmaceuticals, including drugs and nano-/microscale devices. Dr. Clark’s successes in nano-/microbioscience show promising advances in repurposed & next-generation smart technologies useful for diverse medical, industrial, & national defense purposes.